Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
Martin Moylan
St. Paul, Minn.

Boston Scientific buys Plymouth-based Atritech for $375M

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!

Medical device manufacturer Boston Scientific plans to acquire a local firm whose products repair structural heart disease.

Boston Scientific, which employs thousands of workers in the Twin Cities, is trying to reshape itself, selling off some businesses and buying others. The local firm that has caught its eye is Plymouth-based Atritech.

Boston Scientific will pay up to $375 million for the firm. Atritech has developed a device designed to treat patients with atrial fibrillation, the most common type of abnormal heart rhythm. Theses patients are prone to developing blood clots. The clots can dislodge and eventually cause a stroke.

Atritech's Watchman device is designed prevent clots from being dislodged.